# FCER1A

## Overview
The FCER1A gene encodes the alpha subunit of the high-affinity IgE receptor, known as Fc epsilon receptor Ia (FcεRIα), which is a critical component of the immune system's response to allergens. This receptor is categorized as a transmembrane protein and is primarily expressed on the surface of mast cells and basophils, where it plays a pivotal role in mediating allergic reactions by binding to IgE antibodies. The interaction between FcεRIα and IgE facilitates the cross-linking of IgE with allergens, triggering the release of inflammatory mediators that contribute to type I hypersensitivity reactions. Beyond its role in allergic responses, the receptor is also expressed on antigen-presenting cells, aiding in allergen uptake and presentation. Variants in the FCER1A gene have been associated with allergic diseases such as asthma and allergic rhinitis, as well as conditions like cardiac fibrosis, highlighting its clinical significance (Weidinger2008GenomeWide; Portelli2014Genetic; Zhao2021Elevated).

## Structure
The FCER1A gene encodes the alpha subunit of the high-affinity IgE receptor, which plays a critical role in the allergic response. The protein's primary structure is defined by a specific sequence of amino acids that determine its function and interaction capabilities. In terms of secondary structure, the FCER1A protein includes alpha helices and beta sheets, which contribute to its stability and functional conformation. The tertiary structure of the protein forms a three-dimensional shape essential for binding IgE, allowing it to effectively participate in immune responses. 

The quaternary structure of the FCER1A protein involves its association with beta and gamma subunits, forming a functional receptor complex that is crucial for its role in mediating allergic reactions. This multimeric assembly is necessary for the receptor's high-affinity binding to IgE. Post-translational modifications, such as glycosylation, are common in the FCER1A protein and are important for its stability and function. Glycosylation helps maintain the protein's structural integrity and enhances its ability to interact with other molecules, ensuring effective signal transduction in immune responses. These structural features collectively enable the FCER1A protein to fulfill its role in the immune system.

## Function
The FCER1A gene encodes the alpha chain of the high-affinity IgE receptor (FcεRI), which is crucial for mediating allergic responses in healthy human cells. This receptor is primarily expressed on the surface of mast cells and basophils, where it binds to IgE antibodies. Upon binding, the receptor facilitates the cross-linking of IgE with allergens, triggering the release of inflammatory mediators such as histamine and serotonin. This process is a key component of type I hypersensitivity reactions, contributing to the body's defense against parasites and playing a role in allergic diseases (Weidinger2008GenomeWide; Amo2016A).

In addition to its role in mast cells and basophils, the FCER1A-encoded receptor is also expressed on antigen-presenting cells (APCs) like dendritic cells and monocytes. In these cells, the receptor aids in allergen uptake and presentation, promoting the activation of Th2-subsets of T-cells, which are involved in the immune response to allergens (Weidinger2008GenomeWide). The expression of FCER1A is regulated by IgE binding, which enhances its surface expression and protects it from degradation, and is influenced by cytokines such as IL-4 and transcription factors like GATA-1 and GATA-2 (Weidinger2008GenomeWide).

## Clinical Significance
The FCER1A gene is clinically significant due to its association with various allergic and inflammatory conditions. Variants in FCER1A have been linked to allergic diseases such as asthma and allergic rhinitis, with studies showing statistically significant associations (Portelli2014Genetic). In a North Indian population-based study, the rs2427827 SNP in FCER1A was significantly associated with chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with high IgE levels, although no significant association was found with CRSwNP alone (LaulajainenHongisto2020Genomics).

The gene's role extends beyond allergic responses, as it is implicated in cardiac fibrosis. Elevated IgE levels can activate cardiac fibroblasts through the FcεR1 receptor, leading to increased fibrosis-related protein production. This process involves the miR-486a-5p/Smad1 signaling pathway, which contributes to cardiac fibrosis and potentially other cardiovascular conditions (Zhao2021Elevated). The down-regulation of miR-486a-5p in cardiac fibroblasts through IgE-FcεR1 signaling further underscores the gene's role in fibrotic responses (Zhao2021Elevated).

Overall, alterations in FCER1A expression or its interactions can lead to significant clinical outcomes, affecting both allergic and cardiovascular health.


## References


[1. (Weidinger2008GenomeWide) Stephan Weidinger, Christian Gieger, Elke Rodriguez, Hansjörg Baurecht, Martin Mempel, Norman Klopp, Henning Gohlke, Stefan Wagenpfeil, Markus Ollert, Johannes Ring, Heidrun Behrendt, Joachim Heinrich, Natalija Novak, Thomas Bieber, Ursula Krämer, Dietrich Berdel, Andrea von Berg, Carl Peter Bauer, Olf Herbarth, Sibylle Koletzko, Holger Prokisch, Divya Mehta, Thomas Meitinger, Martin Depner, Erika von Mutius, Liming Liang, Miriam Moffatt, William Cookson, Michael Kabesch, H.-Erich Wichmann, and Thomas Illig. Genome-wide scan on total serum ige levels identifies fcer1a as novel susceptibility locus. PLoS Genetics, 4(8):e1000166, August 2008. URL: http://dx.doi.org/10.1371/journal.pgen.1000166, doi:10.1371/journal.pgen.1000166. This article has 230 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1000166)

[2. (LaulajainenHongisto2020Genomics) Anu Laulajainen-Hongisto, Annina Lyly, Tanzeela Hanif, Kishor Dhaygude, Matti Kankainen, Risto Renkonen, Kati Donner, Pirkko Mattila, Tuomas Jartti, Jean Bousquet, Paula Kauppi, and Sanna Toppila-Salmi. Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa. Clinical and Translational Allergy, October 2020. URL: http://dx.doi.org/10.1186/s13601-020-00347-6, doi:10.1186/s13601-020-00347-6. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13601-020-00347-6)

[3. (Amo2016A) Gemma Amo, Jesús García-Menaya, Paloma Campo, Concepción Cordobés, M Carmen Plaza Serón, Pedro Ayuso, Gara Esguevillas, Miguel Blanca, Jose A.G. Agúndez, and Elena García-Martín. A nonsynonymous fcer1b snp is associated with risk of developing allergic rhinitis and with ige levels. Scientific Reports, January 2016. URL: http://dx.doi.org/10.1038/srep19724, doi:10.1038/srep19724. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep19724)

[4. (Zhao2021Elevated) Hongmei Zhao, Hongqin Yang, Chi Geng, Yang Chen, Yaqin Tang, Zhiwei Li, Junling Pang, Ting Shu, Yu Nie, Yongshuo Liu, Kegang Jia, and Jing Wang. Elevated ige promotes cardiac fibrosis by suppressing mir-486a-5p. Theranostics, 11(15):7600–7615, 2021. URL: http://dx.doi.org/10.7150/thno.47845, doi:10.7150/thno.47845. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.47845)

[5. (Portelli2014Genetic) M. A. Portelli, E. Hodge, and I. Sayers. Genetic risk factors for the development of allergic disease identified by genome‐wide association. Clinical &amp; Experimental Allergy, 45(1):21–31, December 2014. URL: http://dx.doi.org/10.1111/cea.12327, doi:10.1111/cea.12327. This article has 143 citations.](https://doi.org/10.1111/cea.12327)